- NAV reached €38.2 billion at 31 December 2024, with NAV per share increasing by 9%
- Strong cash flow generation with dividends received from companies and asset disposals amounting to €1.5 billion in 2024. Active and disciplined capital allocation with increased exposure to Healthcare
- Ordinary dividend to be distributed of approximately €100 million, subject to AGM approval
- Launch of a new €1 billion share buyback program in the form of a Tender Offer starting 27 March 2025 at
a premium of up to 10%
The company will hold its annual investor and analyst call on 27 March 2025 at 15hCET
Files